Cargando…
Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
Autores principales: | Ostuzzi, Giovanni, Papola, Davide, Gastaldon, Chiara, Schoretsanitis, Georgios, Bertolini, Federico, Amaddeo, Francesco, Cuomo, Alessandro, Emsley, Robin, Fagiolini, Andrea, Imperadore, Giuseppe, Kishimoto, Taishiro, Michencigh, Giulia, Nosé, Michela, Purgato, Marianna, Dursun, Serdar, Stubbs, Brendon, Taylor, David, Thornicroft, Graham, Ward, Philip B., Hiemke, Christoph, Correll, Christoph U., Barbui, Corrado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486584/ https://www.ncbi.nlm.nih.gov/pubmed/32919477 http://dx.doi.org/10.1186/s12916-020-01757-w |
Ejemplares similares
-
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020) -
Pharmacological treatment of hyperactive delirium in people with
COVID-19: rethinking conventional approaches
por: Ostuzzi, Giovanni, et al.
Publicado: (2020) -
Safety of psychotropic medications in people with COVID-19
por: Ostuzzi, G., et al.
Publicado: (2021) -
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare
por: Ostuzzi, Giovanni, et al.
Publicado: (2013) -
Esketamine clinical trials: reply to Maju et al.
por: Gastaldon, C., et al.
Publicado: (2020)